NCT02917473

Brief Summary

First-degree relatives of patients with melanoma have a greater risk of developing melanoma. Patients are advised orally to inform their first-degree relatives that they should protect their skin from UV radiation and ask for a skin examination from a general practitioner or dermatologist. The study will evaluate the effectiveness of a written sheet in addition to the usual oral counselling to increase acceptance of skin examination by the first-degree relatives. If effective, written counselling provided to the patient for relatives should be recommended and generalized.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2017

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 28, 2016

Completed
1.2 years until next milestone

Study Start

First participant enrolled

December 13, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2019

Completed
Last Updated

December 30, 2025

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

July 28, 2016

Last Update Submit

December 23, 2025

Conditions

Keywords

Medical skin examinationSkin Self ExaminationSun protection

Outcome Measures

Primary Outcomes (1)

  • Consulting general practitioner or dermatologist

    The number of relatives who will have consulted a dermatologist or a general practitioner to perform whole body skin examination

    1 year

Secondary Outcomes (3)

  • Self-skin examination reported by the relatives

    1 year

  • Sun protection behaviors reported by the relatives

    1 year

  • Barriers to skin examination identified from psychological questionnaires in patients and their relatives

    1 year

Study Arms (2)

Control

OTHER

Education and counseling as commonly delivered to the patients in clinical practice. Brief oral counseling to the patient focusing on sun protection, self-skin examination, medical skin examination, increased risk of melanoma for their first-degree relatives, who should be informed orally by the patients to protect themselves from UV radiation, perform self-skin examination and ask their GP or dermatologist to perform annual skin examination

Behavioral: In-person counselingBehavioral: Medical skin screening

Intervention group

EXPERIMENTAL

Education and counseling as commonly delivered to the patients in clinical practice and written advice for their first-degree relatives. In addition to oral counseling to the patient, written advice will be provided to patients for their relatives focusing on sun protection, self-skin examination, medical skin examination, increased risk of melanoma for first-degree relatives, who should also be informed orally by the patients to protect themselves from UV radiation, perform self-skin examination and ask their GP or dermatologist to perform annual skin examinations.

Behavioral: In-person counselingBehavioral: Written adviceBehavioral: Medical skin screening

Interventions

Written adviceBEHAVIORAL

Written advice

Intervention group

In-person counseling Sun protection

ControlIntervention group

Medical skin screening

ControlIntervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For Patients:
  • Personal history of Stage 0 through IIB melanoma
  • At maximum of 12 weeks after surgical treatment of Stage 0 through IIA melanoma
  • Have at least one first-degree relative
  • Speaking and reading French
  • Affiliated to the French Health Insurance system
  • Signed non-opposition form at the 1 year consultation
  • For 1st degree relatives:
  • To be 1st degree related to a patient with melanoma
  • Speaking and reading French
  • st degree relatives informed by patients and agreeing to fill out the psychological questionnaires and to the use of their personal data by the investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

CHU - ANGERS , Service de Dermatologie

Angers, 49033, France

Location

CHRU BREST Hôpital du Morvan, Institut de Cancérologie et d'Hématologie

Brest, 29000, France

Location

GH La Rochelle Ré Aunis-Service de Dermatologie

La Rochelle, 17000, France

Location

Ch Le Mans

Le Mans, 72000, France

Location

CHU NANTES, Service de Dermatologie

Nantes, 44000, France

Location

CHU-Poitiers _LA MILETRIE POLE MEDIPOOL-DERMATO-ALLERGOLOGIE

Poitiers, 86000, France

Location

CHU -RENNES -Service de Dermatologie-CHU Pontchaillou

Rennes, 35000, France

Location

Centre Eugène Marquis -Service d'Oncologie médicale

Rennes, 35042, France

Location

University Hospital of Tours, Service de Dermatologie

Tours, 37044, France

Location

Related Publications (1)

  • Marce D, Le Vilain-Abraham F, Bridou M, Quereux G, Dupuy A, Lesimple T, Le Corre Y, Wierzbicka-Hainaut E, Legoupil D, Celerier P, Maillard H, Machet L, Caille A. Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial. Cancers (Basel). 2022 Aug 10;14(16):3864. doi: 10.3390/cancers14163864.

MeSH Terms

Conditions

Melanoma

Condition Hierarchy (Ancestors)

Neuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsNeoplasms by SiteSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Laurent MACHET, MD-PHD

    University Hospital, Tours

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2016

First Posted

September 28, 2016

Study Start

December 13, 2017

Primary Completion

April 26, 2019

Study Completion

July 10, 2019

Last Updated

December 30, 2025

Record last verified: 2025-12

Locations